Oral administration of a new HRI activator as a new strategy to improve high‐fat‐diet‐induced glucose intolerance, hepatic steatosis, and hypertriglyceridaemia through FGF21

BACKGROUND AND PURPOSE: FGF21 has emerged as a therapeutic strategy for treating type 2 diabetes mellitus due to its antidiabetic effects, and this has led to the development of long‐acting analogues of FGF21. However, these compounds have some limitations, including a need to be administered by s.c...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Br J Pharmacol
Main Authors: Zarei, Mohammad, Pujol, Eugènia, Quesada‐López, Tania, Villarroya, Francesc, Barroso, Emma, Vázquez, Santiago, Pizarro‐Delgado, Javier, Palomer, Xavier, Vázquez‐Carrera, Manuel
Formáid: Artigo
Teanga:Inglês
Foilsithe: John Wiley and Sons Inc. 2019
Ábhair:
Research Papers
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6555855/
https://ncbi.nlm.nih.gov/pubmed/30927369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.14678
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla